Water soluble flavonol prodrugs that protect against ischaemia-reperfusion injury in rat hindlimb and sheep heart

MedChemComm

Volumn 2, Issue 4, 2011, Pages 321-324

  Williams, Spencer J ^a   Thomas, Colleen J ^b,d   Boujaoude, Mirna ^b   Gannon, Carlie T ^a   Zanatta, Shannon D ^a   Jarrott, Bevyn ^b   May, Clive N ^b   Woodman, Owen L ^b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3',4' DIBENZYLOXYFLAVONOL; 4' BENZYLOXYFLAVONOL; CALCIUM ION; FLAVONOL DERIVATIVE; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HINDLIMB; HYDROPHILICITY; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SHEEP; THORACIC AORTA; VASODILATATION;

ANIMALIA; OVIS ARIES; RATTUS;

EID: 79953850388     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c0md00240b     Document Type: Article

References (22)

1. D. M. Yellon and D. J. Hausenloy, N. Engl. J. Med., 2007, 357, 1121-1135.
2. R. J. Burns, R. J. Gibbons, Q. Yi, R. S. Roberts, T. D. Miller, G. L. Schaer, J. L. Anderson and S. Yusuf, J. Am. Coll. Cardiol., 2002, 39, 30-36.
3. J. L. Zweier and M. A. Talukder, Cardiovasc. Res., 2006, 70, 181-190.
4. S. J. Klebanoff, J. Leukocyte Biol., 2005, 77, 598-625.
5. P. Pacher, J. S. Beckman and L. Liaudet, Physiol. Rev., 2007, 87, 315-424.
6. U. Forstermann, Nat. Clin. Pract. Cardiovasc. Med., 2008, 5, 338-349.
7. (a) M. G. Hertog, E. J. Feskens, P. C. Hollman, M. B. Katan and D. Kromhout, Lancet, 1993, 342, 1007-1011;
8. (b) M. G. Hertog, E. J. Feskens and D. Kromhout, Lancet, 1997, 349, 699.
9. (a) E. C. Chan, P. Pannangpetch and O. L. Woodman, J. Cardiovasc. Pharmacol., 2000, 35, 326-333;
10. (b) C. X. Qin, X. Chen, R. A. Hughes, S. J. Williams and O. L. Woodman, J. Med. Chem., 2008, 51, 1874-1884;
11. (c) S. Yap, K. J. Loft, O. L. Woodman and S. J. Williams, ChemMedChem, 2008, 3, 1572-1579.
12. O. L. Woodman, W. F. Meeker and M. Boujaoude, J. Cardiovasc. Pharmacol., 2005, 46, 302-309.
13. S. Wang, G. J. Dusting, C. N. May and O. L. Woodman, Br. J. Pharmacol., 2004, 142, 443-452.
14. S. Wang, C. J. Thomas, G. J. Dusting, O. L. Woodman and C. N. May, Eur. J. Pharmacol., 2009, 624, 31-37.
15. S. Wang, K. Fei, Y. W. Xu, L. X. Wang and Y. Q. Chen, Chin. Med. J., 2009, 122, 61-67.
16. C. L. Roulston, J. K. Callaway, B. Jarrott, O. L. Woodman and G. J. Dusting, Eur. J. Pharmacol., 2008, 584, 100-110.
17. C. G. Wermuth, in The practice of medicinal chemistry, ed. C. G. Wermuth, Elsevier, London, UK, 2003, pp. 617-630.
18. F. A. van Acker, J. A. Hageman, G. R. Haenen, W. J. van Der Vijgh, A. Bast and W. M. Menge, J. Med. Chem., 2000, 43, 3752-3760.
19. M. J. Song, I. Baek, M. Seo, S.-H. Kim, K. Suk, O. L. Woodman, S. J. Williams and I.-K. Kim, Clin. Exp. Pharmacol. Physiol., 2010, 37, 803-810.
20. M. P. Skatchkov, D. Sperling, U. Hink, A. Mulsch, D. G. Harrison, I. Sindermann, T. Meinertz and T. Munzel, Biochem. Biophys. Res. Commun., 1999, 254, 319-324.
21. (a) J.M. Downey and M. V. Cohen, Circ. J., 2009, 73, 1171-1177;
22. (b) A. Prasad, G. W. Stone, D. R. Holmes and B. Gersh, Circulation, 2009, 120, 2105-2112.